Literature DB >> 26633543

Economic evaluation of whole-genome sequencing in healthy individuals: what can we learn from CEAs of whole-body CT screening?

Christine Y Lu1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26633543     DOI: 10.1038/gim.2015.159

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  4 in total

1.  Cost-effectiveness of whole-body CT screening.

Authors:  Molly T Beinfeld; Eve Wittenberg; G Scott Gazelle
Journal:  Radiology       Date:  2005-02       Impact factor: 11.105

2.  The economic value of personalized medicine tests: what we know and what we need to know.

Authors:  Kathryn A Phillips; Julie Ann Sakowski; Julia Trosman; Michael P Douglas; Su-Ying Liang; Peter Neumann
Journal:  Genet Med       Date:  2013-10-17       Impact factor: 8.822

Review 3.  Issues surrounding the health economic evaluation of genomic technologies.

Authors:  James Buchanan; Sarah Wordsworth; Anna Schuh
Journal:  Pharmacogenomics       Date:  2013-11       Impact factor: 2.533

4.  The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.

Authors:  Caroline S Bennette; Carlos J Gallego; Wylie Burke; Gail P Jarvik; David L Veenstra
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822

  4 in total
  2 in total

Review 1.  Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.

Authors:  Kathryn A Phillips; Patricia A Deverka; Deborah A Marshall; Sarah Wordsworth; Dean A Regier; Kurt D Christensen; James Buchanan
Journal:  Value Health       Date:  2018-08-08       Impact factor: 5.725

2.  DNA-based screening and personal health: a points to consider statement for individuals and health-care providers from the American College of Medical Genetics and Genomics (ACMG).

Authors:  Lora J H Bean; Maren T Scheuner; Michael F Murray; Leslie G Biesecker; Robert C Green; Kristin G Monaghan; Glenn E Palomaki; Richard R Sharp; Tracy L Trotter; Michael S Watson; Cynthia M Powell
Journal:  Genet Med       Date:  2021-03-31       Impact factor: 8.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.